emanelayeh@gmail.com
Eman Elayeh holds a Master’s degree in Clinical Pharmacy (2010, University of Jordan) and is currently pursuing a PhD in pharmaceutical sciences at the same institution. Her thesis, titled "Integrated Proteomics and Metabolomics to Identify Potential Biomarkers for Predicting Micro-metastasis and Therapeutic Response to Immune Checkpoint Inhibitors (ICI) in Non-Small Cell Lung Cancer (NSCLC) Patients," focuses on cutting-edge research in cancer treatment.